Home
>
National Drug Code (NDC)
>
Ketorolac Tromethamine
Ketorolac Tromethamine - 10019-029-02 - (Ketorolac Tromethamine)
Drug Information of Ketorolac Tromethamine
| Product NDC: | 10019-029 |
| Proprietary Name: | Ketorolac Tromethamine |
| Non Proprietary Name: | Ketorolac Tromethamine |
| Active Ingredient(s): | 15 mg/mL & nbsp; Ketorolac Tromethamine |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ketorolac Tromethamine
| Product NDC: | 10019-029 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075772 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100629 |
Package Information of Ketorolac Tromethamine
| Package NDC: | 10019-029-02 |
| Package Description: | 25 VIAL in 1 PACKAGE (10019-029-02) > 2 mL in 1 VIAL (10019-029-12) |
NDC Information of Ketorolac Tromethamine
| NDC Code | 10019-029-02 |
| Proprietary Name | Ketorolac Tromethamine |
| Package Description | 25 VIAL in 1 PACKAGE (10019-029-02) > 2 mL in 1 VIAL (10019-029-12) |
| Product NDC | 10019-029 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ketorolac Tromethamine |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20100629 |
| Marketing Category Name | ANDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | KETOROLAC TROMETHAMINE |
| Strength Number | 15 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
